4.7 Article

Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 20, 期 22, 页码 6751-6757

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2012.09.030

关键词

Hedgehog signaling; Smoothened; High-throughput screening; Smo antagonist; Smo mutation

资金

  1. Pediatric Brain Tumor Foundation
  2. Clinical Oncology Research Center [5K12-CA100639-08]
  3. NIH
  4. NSF
  5. NC Biotechnology Center
  6. Duke University
  7. [5RO1 CA113656-03]

向作者/读者索取更多资源

The Hedgehog signaling pathway plays an essential role in embryo development and adult tissue homeostasis, in regulating stem cells and is abnormally activated in many cancers. Given the importance of this signaling pathway, we developed a novel and versatile high-throughput, cell-based screening platform using confocal imaging, based on the role of beta-arrestin in Hedgehog signal transduction, that can identify agonists or antagonist of the pathway by a simple change to the screening protocol. Here we report the use of this assay in the antagonist mode to identify novel antagonists of Smoothened, including a compound (A8) with low nanomolar activity against wild-type Smo also capable of binding the Smo point mutant D473H associated with clinical resistance in medulloblastoma. Our data validate this novel screening approach in the further development of A8 and related congeners to treat hedgehog related diseases, including the treatment of basal cell carcinoma and medulloblastoma. (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据